FY2025 · period end Dec '25 · from the 10-K filed Mar 19, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B |
| Net Income | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B |
| EPS (Diluted) | negative: -$0.01 | negative: -$0.01 | negative: -$0.01 | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stockholders' Equity | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B |
| Cash & Equivalents | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B |
| Capital Expenditures | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B | negative: -$0.00B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | — | — | — | — | — |
| Net Margin | — | — | — | — | — |
| Return on Equity | 77.6% | 49.9% | 85.8% | 168.0% | 153.2% |
| Return on Assets | negative: -205.6% | negative: -117.3% | negative: -286.0% | negative: -269.0% | negative: -156.7% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001493152-26-036714 | Jun 30, 2026 | Aug 10, 2026 | Aug 10, 2026 10:05 UTC | EDGAR |
| 8-K | 0001493152-26-027806 | Jun 8, 2026 | Jun 9, 2026 | Jun 9, 2026 01:54 UTC | EDGAR |
| 10-Q | 0001493152-26-021038 | Mar 31, 2026 | May 4, 2026 | May 4, 2026 16:06 UTC | EDGAR |
| 10-K | 0001493152-26-011555 | Dec 31, 2025 | Mar 19, 2026 | Mar 19, 2026 15:17 UTC | EDGAR |
| 10-Q | 0001493152-25-019032 | Sep 30, 2025 | Oct 23, 2025 | Oct 23, 2025 17:02 UTC | EDGAR |
| 10-Q | 0001641172-25-021604 | Jun 30, 2025 | Jul 31, 2025 | Jul 30, 2025 22:16 UTC | EDGAR |
| 10-Q | 0001641172-25-007701 | Mar 31, 2025 | Apr 30, 2025 | Apr 30, 2025 20:00 UTC | EDGAR |
| 10-K | 0001493152-25-010854 | Dec 31, 2024 | Mar 19, 2025 | Mar 19, 2025 10:15 UTC | EDGAR |
Direct links to SEC EDGAR. BIOF has additional filings available on the SEC site.
6 numbers BLUE BIOFUELS, INC. later changed — same XBRL tag, both filings linked.
Assets·As of Dec 31, 2014
Major restatementwas$8.3M
Revised down in a 10-Q.
Operating Income (Loss)·Q1 2024
Major restatementwas-$576.7K
Revised down in a 10-Q.
Net Income (Loss) Attributable to Parent·Q3 2024
Major restatementwas-$619.9K
Revised down in a 10-Q.
Net Income (Loss) Attributable to Parent·Q3 2012
Major restatementwas-$79.8K
Revised up in a 10-Q.
Operating Income (Loss)·Q2 2014
Major restatementwas-$2.3M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q3 2013
Major restatementwas-$88.1K
Revised down in a 10-Q/A.
BIOF is not the only one.
See every restatement we've found across the market — or get an alert the next time BIOF revises a number.
Restatements are detected by comparing every vintage of a fact across all of BLUE BIOFUELS, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows BIOF's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling BLUE BIOFUELS, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on BIOF yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on BIOF and publish the result to your public profile.
Ask about BLUE BIOFUELS, INC.
Continue in Workspace — cited answers on BIOF, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs